New pharmacological approaches in heart failure therapy: developments and possibilities

Cuthbert, J. J., Pellicori, P. , Shah, P. and Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13(2), pp. 173-188. (doi: 10.2217/fca-2016-0068) (PMID:28181443)

Full text not currently available from Enlighten.


There have been few major breakthroughs in heart failure (HF) drug therapies in recent years yet HF morbidity and mortality remain high, and there is a clear need for further research. Several newer agents that appear promising in Phase I and II trials do not progress to show clinical benefit in later trials. Part of the failure to find new therapies may lie in flawed trial design compounded by the need for ever-increasing patient numbers in order to prove outcome benefit. We summarize some of the most recent and promising medical therapies for HF.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Pellicori, Dr Pierpaolo
Authors: Cuthbert, J. J., Pellicori, P., Shah, P., and Clark, A. L.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
Journal Name:Future Cardiology
Publisher:Future Medicine
ISSN (Online):1744-8298
Published Online:09 February 2017

University Staff: Request a correction | Enlighten Editors: Update this record